EnWave Announces Details of Private-Label Order and Increased Distribution of …
… a global leader in the production of vegetables; Hormel Foods Corporation, a major processed meat manufacturer in the United States of America; and Sutro Biopharma, a company developing a protein synthesis process for the pharmaceutical industry.
Read more on MarketWatch
Toxin-secreting stem cells to treat brain tumors
Pseudomonas exotoxin (PE) potently blocks protein synthesis by catalyzing the inactivation of elongation factor-2 (EF-2), and PE-cytotoxins have been used as anti-tumor agents. However, their effective clinical translation in solid tumors has been …
Read more on Next Big Future
Genetically Engineered Stem Cells Against Brain Cancer
"After doing all of the molecular analysis and imaging to track the inhibition of protein synthesis within brain tumors, we do see the toxins kill the cancer cell's. Cancer-causing toxins have been used with great success in a variety of blood cancers …
Read more on Youth Health Magzine
Frederick, MD (PRWEB) September 15, 2014
BioFactura, Inc. is a collaborator on a grant awarded to the Geneva Foundation. Ebola drug development funding will be provided under a Partnerships for Biodefense grant from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID). The project team is led by the Geneva Foundation (Seattle, WA) and includes partners at the US Army Medical Research Institute of Infectious Diseases (USAMRIID, Ft. Detrick, MD) and the Fraunhofer USA Center for Molecular Biotechnology (Newark, DE). During the 5-year grant, the team aims to develop an effective monoclonal antibody (mAb)-based drug against Sudan ebolavirus.
Currently, there are no established treatments for Ebola infection. Over the past five years, three Ebola
outbreaks involving a Sudan strain of the virus have occurred. The need for strain-specific Ebola countermeasures is imperative for treating infected patients and effectively containing outbreaks. Theresearch team looks forward to developing a promising and urgently needed Ebola treatment that targets the Sudan strain of the virus.
About BioFactura, Inc.
BioFactura develops and commercializes high-value novel and generic biopharmaceuticals (biosimilars) using its patented StableFast™ Biomanufacturing Platform. The Company accomplishes this mission through partnering and licensing agreements with academic institutions, federal laboratories, and mid- to large-pharma companies. The spectrum of these programs ranges from grant- and contract-funded early-stage drug development to advancing and commercializing BioFactura’s in-house products at the preclinical and early clinical stages.
About the Geneva Foundation
The Geneva Foundation (Geneva), is a non-profit organization headquartered in Tacoma, WA. Established in April 1993, Geneva’s mission is to support and advance innovative medical research and excellence in education within the U.S. military. We build enduring partnerships dedicated to the health and well-being of U.S. service members, their families, and the global community. Through these partnerships, Geneva connects military researchers to educational and research opportunities in a variety of therapeutic areas. We strive to work hand-in-hand with our partners to shape the future of military medicine.
About the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
USAMRIID’s mission is to protect the warfighter from biological threats and to be prepared to investigate
disease outbreaks or threats to public health. Research conducted at USAMRIID leads to medical solutionsvaccines, drugs, diagnostics, and information-that benefit both military personnel and civilians. The Institute plays a key role as the lead military medical research laboratory for the Defense Threat Reduction Agency’s Joint Science and Technology Office for Chemical and Biological Defense. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Materiel Command.
About the Fraunhofer USA Center for Molecular Biotechnology Located in Newark, Delaware, FhCMB is developing a safe, rapid and economical alternative for production of vaccines and therapeutics. The Center conducts research in the area of plant biotechnology, utilizing new, cutting edge approaches to assist the diagnosis, prevention and treatment of human and animal diseases. The Center houses individuals with expertise and excellence in plant virology, pathology, molecular biology, immunology, protein engineering, biochemistry, quality assurance, and quality control, regulatory and clinical affairs. The Center’s GMP production facility provides complete capabilities from target expression through Phase 1 and 2 clinical product development.
The information contained in this press release does not necessarily reflect the position or the policy of the
Government and no official endorsement should be inferred. Statements in this press release that are not strictly historical facts are “forward looking” statements (identified by the words “believe”, “estimate”, “project”, “expect” or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company’s products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon
information currently known to management, and the Company does not undertake any obligation to publicly update or revise any forward-looking statements.
World Economic Forum Recognizes Rensselaer Professor Peter Tessier as One …
In 2012, he received a Rensselaer Early Career Award and the Rensselaer School of Engineering Research Excellence Award. In 2014, he received an Alexander von Humboldt Fellowship to support his research at the Max Planck Institute of Biochemistry in …
Read more on Rensselaer Polytechnic Institute
First detailed picture of a cancer-related cell enzyme in action on a chromosome
"The nucleosome is a key target of the enzymes that conduct genetic processes critical for life," said Song Tan, professor of biochemistry and molecular biology at Penn State and the leader of the study's research team. The Penn State scientists …
Read more on Penn State News
Clock gene dysregulation may explain overactive bladder
… body physiology and aging-related dysfunction and ultimately lead to new strategies of treatment by targeting the circadian regulatory process, including non-drug treatment approaches," said Changhao Wu, M.D., Ph.D., a researcher involved in the …
Read more on EurekAlert (press release)
Pittsburgh, PA (PRWEB) May 15, 2014
The Spectroscopy Society of Pittsburgh (SSP), one of two Pittcon conference and exposition sponsors, is pleased to announce the 2015 Pittsburgh Spectroscopy Award recipient: Alfred G. Redfield, Professor of Biochemistry and Physics, Emeritus, Brandeis University (Massachusetts).
This prestigious award, established in 1957, honors an individual who has made outstanding contributions in the field of spectroscopy. The award committee selected Redfield based on his many accomplishments in the advanced understanding, practical developments and applications in the field of nuclear magnetic resonance especially in nuclear-spin relaxation, as well as his leadership role in the scientific community and mentorship of young scientists.
Dr. Redfield is also a Member of the National Academy of Sciences and a Fellow of the American Academy of Arts and Sciences. His additional awards after 2003 include the Biophysics Prize, American Physical Society (2005), Max Delbruck Prize in Biological Physics (2006), and the Russell Varian Lecture and Prize (2007). During his 60+ year career, he has published more than 200 papers.
The award will be presented during Pittcon 2015, which will be held in New Orleans, LA, March 8-12, Morial Convention Center.
About the SSP
The Spectroscopy Society of Pittsburgh (SSP), along with its sister society, the Society for Analytical Chemists of Pittsburgh (SACP), is a non-profit organization dedicated to furthering science education in the Western Pennsylvania region. With support from the net proceeds from Pittcon, the SSP supports member education programs, teacher and student awards, a wide variety of educational programs, and grant programs for high schools, colleges, and beginning university professors.
Pittcon® is a registered trademark of The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, a Pennsylvania non-profit organization. Co-sponsored by the Spectroscopy Society of Pittsburgh and the Society for Analytical Chemists of Pittsburgh, Pittcon is the premier annual conference and exposition on laboratory science. Proceeds from Pittcon fund science education and outreach at all levels, kindergarten through adult. Pittcon donates more than a million dollars a year to provide financial and administrative support for various science outreach activities including science equipment grants, research grants, scholarships and internships for students, awards to teachers and professors, and grants to public science centers, libraries and museums. Visit pittcon.org for more information.
Elsevier Adding Classic Science and Humanties Ebooks to Legacy Collection
New subject areas for Elsevier's offerings include arts and humanities; computer science; economics, econometrics and finance; immunology and microbiology; and mathematics. Newly digitized books in the engineering and the biochemistry, genetics, and …
Read more on Campus Technology
Elsevier Adds Five New Subject Areas to Legacy eBook Collection
WALTHAM, MA–(Marketwired – October 06, 2014) – Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced its Legacy eBook Collection on ScienceDirect now includes five new subject areas.
Read more on Yahoo Finance UK
Elsevier Wins Six First Prizes at BMA Medical Book Awards Competition
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that 28 of its professional and scholarly products were honored at the British Medical Association's annual BMA Medical Book …
Read more on Broadway World
UT Southwestern Professor Awarded .5 million Moore Investigators Grant
Having earned an undergraduate degree in biochemistry from Rice University and a Ph.D. in biophysics from the University of California, Berkeley, Reynolds moved to UT Southwestern for a postdoctoral fellowship on the evolution and engineering of …
Read more on BioNews Texas
Scientists solve mystery of antibiotic agent that kills microorganisms
According to the biochemistry professor Satish K. Nair who assisted Prof. Donk “Ortega discovered that the dehydratase did two things. One is that it added glutamate (to the nisin peptide), and the second thing it did was it eliminated glutamate. But …
Read more on The American Bazaar
Missouri S&T student team cleans up coal
Missouri S&T's chapter of iGEM, the International Genetically Engineered Machine Foundation, is preparing to present its research findings as part of the iGEM 2014 Giant Jamboree to be held Oct. 30 through Nov. 3 in Boston. S&T's iGEM team will compete …
Read more on The Rolla Daily News
Sex editor Eirini Xeridiri talks about the evolution of sex and feelings in time. The truth is that we fall in love because cannot do otherwise. All of our o…
Video Rating: 4 / 5